{
    "code": "01048516",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01048516",
    "time": "2021-12-24 06:41:47",
    "許可證字號": "衛署藥製字第048516號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/15",
    "發證\/登錄日期": "96\/01\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00104851600",
    "中文品名": "羅喜糖 膜衣錠4毫克",
    "英文品名": "Rosizone Film Coated Tablets 4mg",
    "適應症": "Rosiglitazone是一種thiazolidinedione類之抗糖尿病藥品，適用於與飲食控制及運動配合治療，以改善第二型糖尿病成人患者的血糖控制效果",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝 2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ROSIGLITAZONE MALEATE",
    "限制項目": "01國　產 1R不得製造 25監視中學名藥 61完成BE試驗",
    "申請商名稱": "0502110200  永信藥品工業股份有限公司",
    "申請商地址": "台中市大甲區頂店里中山路一段1191號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400810",
            "成分名稱": "ROSIGLITAZONE MALEATE",
            "含量描述": "(4)",
            "含量": "5.3000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010485160002-104-11-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048516&Seq=007&Type=9"
        },
        {
            "title": "衛署藥製字第048516號(3)-104-03-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048516&Seq=006&Type=8"
        }
    ]
}